Mets Trade for Yoshida to Boost Lineup

Welcome to New York meds news today.

Two minutes of updates that matter to New York meds fans, hit subscribe and stay connected.

The New York meds bolstered their roster this off season, but right field and designated

hitter spots still need work.

Fansighted writer Chris Landers suggests trading with the boss and Red Sox for outfielder

Masataka Yoshida to fill those roles.

Yoshida impressed in the 2026 World Baseball Classic, sparking talk of a deal.

Yoshida argues Brett Beatty is not to fix for either position.

He sees Yoshida as a versatile option who could strengthen the bottom of the meds lineup.

The proposal might send Mark Vientos to Boston, where a change could revive his career.

Yoshida has solid numbers over three years with the Red Sox.

He is hitting 282 with a free 37 on base percentage, posting 65 doubles, 29 home runs, and 100.

54 runs, batted in across 303 games.

That production fits perfectly for a designated hitter.

He is a year four, of a five year, $90 million contract.

The meds have the payroll flexibility to absorb the remaining salary, making this feasible

without much cost and prospects.

This move could be the final piece to push New York over the top and the national league.

Talks remain speculative, but is worth watching as spring training nears.

This episode is brought to you by our sponsor, See the episode description.

A pillow that plays your podcasts, music, or white noise privately.

No earbuds required.

S-O-L-L-I, solelypillow.com.